SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Stafi is the first DeFi protocol unlocking liquidity of staked assets. Users can stake PoS tokens through Stafi and receive rTokens in return, which are available for trading while still earning staking rewards. FIS is the native token on Stafi Chain. FIS is required to provide security to the network by staking, pay for transaction fees on the Stafi chain, mint &amp; redeem rTokens.

StaFi

StaFi is trending as community members discuss a potential token burn proposal aimed at creating deflationary pressure and a new roadmap focused on AI-powered liquid staking. Despite recent exchange delisting concerns, bulls remain focused on the token's low market cap and its utility within the liquid staking sector, leading to active speculation about its short-term breakout potential.

COAR is a community-driven meme token on the Solana blockchain built around the theme of oil and energy. The project brings together a growing community of crypto enthusiasts who share an interest in energy-themed digital assets. COAR operates as a fully decentralized token with active trading on Solana decentralized exchanges. The token has a fixed maximum supply of 1 billion units with 6 decimal places, and its mint authority has been permanently revoked, making the supply immutable. The project features a dedicated website at coargov.com with real-time market data integration via DexScreener.

Chinese Oil Asset Reserve

COAR is gaining attention through a combination of oil-sector tokenization narratives, viral cultural memes, and speculative momentum. Market participants are actively debating the token's sustainability while scrutinizing its limited holder base and the aggressive community-driven hype surrounding its launch.

Fidelity National Information Services, Inc. engages in the provision of technology solutions for financial institutions and businesses. It operates through the following segments: Banking Solutions, Capital Markets Solutions, and Corporate and Other. The Banking Solutions segment focuses on serving financial institutions with core processing software, transaction processing software, and complementary applications and services. The Capital Markets Solutions segment provides global financial services with buy- and sell-side solutions. The Corporate and Other segment includes corporate overhead expense, leveraged functions, and miscellaneous expenses. The company was founded in 1968 and is headquartered in Jacksonville, FL.

Fidelity National Information Services, Inc.

Fidelity National Information Services is trending due to a major pivot toward AI-integrated financial crime detection through a strategic partnership with Anthropic. Investors and the community are actively debating the stock's future, balancing optimism over these high-tech AI initiatives and new digital currency networks against concerns regarding legacy strategic missteps and weak guidance.

Leidos Holdings, Inc. engages in providing services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

Leidos Holdings Inc

Leidos Holdings is drawing significant investor attention following a major defense contract win that bolsters its position in critical national security and hypersonic technology programs. While the stock has faced some volatility and recent price pullbacks, the community remains actively engaged in debating the company's long-term valuation versus its significant backlog and integration into high-priority government defense initiatives.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp is trending as investors weigh the impact of proposed energy auctions requiring tech firms to fund new power plants, a move causing volatility in power-generation stocks like VST and CEG. While institutional interest remains high due to the company's long-term contracts with major hyperscalers, the community is actively debating whether this policy shift creates a necessary grid expansion or a headwind for current profit margins.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is attracting heavy attention as a leader in perpetual exchange volume, with the community closely tracking its integration into major institutional frameworks and its performance relative to broader crypto benchmarks. Traders are actively debating the impact of upcoming token unlocks and the potential for a long-term supply squeeze as the ecosystem continues to expand its revenue-generating capabilities.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is experiencing significant volatility as investors weigh strong backlog growth and contract wins against broader sector-wide weakness and algorithmic trading pressures. While the community remains divided between long-term confidence in the company's defense and energy initiatives and frustration over persistent price declines, many participants are viewing the current dip as a potential accumulation opportunity.

ProShares Trust - ProShares UltraPro Short S&P 500

ProShares UltraPro Short S&P 500 ETF

The ProShares UltraPro Short S&P 500 ETF (SPXU) is trending as traders hedge against potential market instability, with the community actively debating the timing of a major market correction and the impact of geopolitical tensions. Participants are closely monitoring moving averages and technical support levels while sharing strategies for managing leveraged inverse positions amidst ongoing market volatility.

Innovative Solutions & Support, Inc. engages in the manufacture of flight navigation systems. It designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. It supplies integrated flight management systems, flat panel display systems, integrated standby units, and global positioning system receivers. The company was founded by Geoffrey S. M. Hedrick on February 12, 1988 and is headquartered in Exton, PA.

Innovative Solutions And Support Inc

Innovative Solutions And Support Inc is trending as investors react to fiscal second-quarter 2026 earnings that included a year-over-year revenue increase alongside discussions regarding the company's long-term revenue targets and recent strategic product acquisitions. Community sentiment remains focused on the company's growth trajectory and its ability to execute on integration initiatives, with some participants noting volatility in recent price action.

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Relay Therapeutics Inc

Relay Therapeutics is facing heightened volatility following the release of interim data for its PI3Kalpha inhibitor, RLY-2608, with the community actively debating whether the safety profile outweighs current efficacy concerns. While analysts maintain generally positive long-term ratings, investors are divided on the stock's direction as they digest the trial results and look ahead to upcoming management presentations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for PTC Therapeutics (PTCT) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +93.35% and +16.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results PR Newswire...

Exploring Analyst Estimates for PTC Therapeutics (PTCT) Q1 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for PTC Therapeutics (PTCT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2026.

Horizon Investments LLC Takes $3.06 Million Position in PTC Therapeutics, Inc. $PTCT

Horizon Investments LLC acquired a new stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 40,333 shares of the biopharmaceutical company's stock, va...

Agenus (AGEN) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Agenus (AGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PTC Therapeutics to Participate in Upcoming Investor Conferences

PTC Therapeutics to Participate in Upcoming Investor Conferences PTC Therapeutics to Participate in Upcoming Investor Conferences PR Newswire WARREN, N.J., May 4, 2026 WARREN, N.J., May 4, 2026...

Vanguard Group Inc. Purchases 514,204 Shares of PTC Therapeutics, Inc. $PTCT

Vanguard Group Inc. raised its position in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) by 6.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,803,203 shares of th...

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PTC Therapeutics (PTCT) Expected to Announce Earnings on Thursday

PTC Therapeutics (NASDAQ:PTCT) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.27	--	--	N/A
Q1 '26	-$0.47	-$0.03	93.64%	BEAT
Q4 '25	$0.10	-$1.67	-1720.89%	MISSED
Q3 '25	-$1.13	$0.20	117.65%	BEAT
Q2 '25	-$1.02	-$0.83	18.74%	BEAT

PTCT
PTC Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest PTCT News

PTCTPTC Therapeutics Inc